Markets / IPO / Nephrocare Health Services

Nephrocare Health Services IPO

Updated 17:56

Mainboard IPO on NSE and BSE · Healthcare Service Provider

Status
Listed
Price band
₹438–460
Lot size
32 shares · ₹14,720
Subscribed
13.96×

How it listed

Issue price
₹460
Listing price (open)
₹490.00 +6.52%
First-day close
₹471.25 +2.45%
Price now
₹601.75 +30.82%
Listing day17 Dec 2025
Open / high / low / close₹490.00 / ₹499.00 / ₹463.80 / ₹471.25
Shares traded on NSE1,53,51,924
Market value at the listing-day close₹4,739 cr

Closing prices since listing: 26 Oct ₹607.40, 27 Oct ₹634.60, 28 Oct ₹628.40, 29 Oct ₹628.55, 30 Oct ₹614.55, 2 Nov ₹624.30, 3 Nov ₹624.60, 4 Nov ₹622.35, 5 Nov ₹603.10, 6 Nov ₹605.95.

Nephrocare Health Services share price, live chart and technicals →

Key dates

Bidding opens10 Dec 2025
Bidding closes12 Dec 2025
Allotment15 Dec 2025
Refunds and shares in demat16 Dec 2025
Listing17 Dec 2025

Issue reservation

Investor groupShares% of issueMost applicants allotted
Institutions (QIB)36,78,79327.48%–
HNI / NII28,86,27021.56%–
  HNI, above ₹10 lakh19,24,18014.37%884
  HNI, ₹2–10 lakh9,62,0907.19%2,147
Retail67,34,63050.30%2,10,457
Employees88,1610.66%–

Shares NSE lists as offered to each group, plus the anchor portion. "Most applicants allotted" is how many people can get the minimum application in that group when it is oversubscribed.

Lot size by investor type

ApplicationLotsSharesAmount
Retail (minimum)132₹14,720
Retail (maximum)13416₹1,91,360
Small HNI (minimum)14448₹2,06,080
Small HNI (maximum)672,144₹9,86,240
Big HNI (minimum)682,176₹10,00,960

At ₹460 a share. Retail bids go up to ₹2 lakh, small HNI from ₹2 lakh to ₹10 lakh, big HNI above ₹10 lakh.

Chance of getting shares (retail)

Chance
At least 1 in 2
Retail allotments available
2,10,457 × one lot
Retail portion subscribed
2.31×

An estimate from the times the retail portion was subscribed, as if every applicant bid for the minimum. Many bid for more lots, so the real chance is usually better. Winners are picked by lottery and each gets the minimum (one lot).

Subscription

Investor categoryShares offeredShares bid forTimes subscribed
Institutions (QIB)36,78,79310,10,69,08827.47×
HNI / NII28,86,2707,00,52,35224.27×
  HNI, above ₹10 lakh19,24,1805,73,66,08029.81×
  HNI, ₹2–10 lakh9,62,0901,26,86,27213.19×
Retail67,34,6301,55,38,3042.31×
Employees88,1612,35,1362.67×
Total1,33,87,85418,68,94,88013.96×

NSE and BSE bids together, as of 12 Dec 2025 19:00.

Demand at each price

Top price ₹4601,738.12 lakh shares93.0%
Cut-off final price, whatever it is; mostly retail129.75 lakh shares6.9%
Lower prices ₹438–4591.37 lakh shares0.1%

Shares bid on NSE and BSE at each price in the band. Most bids at the top price, and little at lower prices, means buyers were keen.

Anchor investors

Anchor bid date9 Dec 2025
Lock-in ends for the first 50% (30 days)13 Jan 2026
Lock-in ends for the remaining 50% (90 days)14 Mar 2026

Anchor investors are large funds that buy the day before the IPO opens. SEBI locks in half their shares for 30 days from the allotment and the rest for 90 days; they can sell from the next trading day. Traders watch these dates because extra selling can come in.

Financials and valuation

At issue priceNow
Market value₹4,626 cr₹6,051 cr
P/E (last 12 months' profit)36.147.2
Revenue, last 12 months₹1,111 cr
Profit, last 12 months₹128 cr
Return on equity10.8%
Debt to equity0.07

From results the company filed with NSE (latest period to 30 Sept 2026). Twelve-month figures need four quarters of results, so they fill in over the first year after listing.

Other recent IPOs: Healthcare Service Provider

CompanyListedSubscribedOn listingSince IPO
Credent Connect N Care SME20 Aug–+90.00%+106.24%
Pramodini Medicare SME19 Aug–+1.69%-8.94%
Gaudium IVF and Women Health 27 Feb7.27×+5.06%+31.87%
Invicta Diagnostic SME8 Dec–+17.65%-18.59%
Chandan Healthcare SME17 Feb–+3.84%+47.48%
Suraksha Diagnostic 6 Dec1.27×-0.68%-24.37%

IPO details

Price band₹438–460
Final issue price₹460
Lot size32 shares
Minimum investment₹14,720 (1 lot)
MarketNSE mainboard
Issue type100% Book Building
Face value₹2 per Equity Share
IndustryHealthcare Service Provider
Issue size₹871.05 crore (about 1.89 crore shares) · Fresh issue + offer for sale: fresh ₹353.41 cr, offer for sale ₹517.64 cr
ISININE428V01029
RegistrarKFin Technologies Limited
Helpline: +91 40 6716 2222, nephrocare.ipo@kfintech.com
Lead managersICICI Securities Limited, Ambit Private Limited, IIFL Capital Services Limited and Nomura Financial Advisory and Securities (India) Private Limited
ProspectusRed herring prospectus (NSE)

Check allotment status

Allotment was finalised on 15 Dec 2025. Check it on the registrar's page (KFin Technologies Limited), NSE or BSE with your PAN or application number.

← All IPOs: open, upcoming and recently listed

From NSE's official IPO data. Expected dates follow SEBI's T+3 timetable; the exchange confirms them. Information only, not investment advice.

What is the Nephrocare Health Services IPO price band and lot size?

The price band is ₹438–460 per share, and one lot is 32 shares (₹14,720 at the upper price).

When is the Nephrocare Health Services IPO allotment date?

Allotment was finalised on 15 Dec 2025, the next working day after bidding closed on 12 Dec 2025.

How many times was the Nephrocare Health Services IPO subscribed?

In total 13.96 times, on NSE and BSE together; retail 2.31 times.

What is the Nephrocare Health Services IPO listing date?

It listed on 17 Dec 2025 on NSE and BSE.

What is the chance of getting Nephrocare Health Services IPO shares?

At least 1 in 2 retail applicants got the minimum lot: 2,10,457 retail allotments with the retail portion subscribed 2.31 times. Winners are picked by lottery.

When does the Nephrocare Health Services anchor lock-in end?

The 30-day lock-in on half of the anchor investors' shares ends on 13 Jan 2026 and the 90-day lock-in on the rest ends on 14 Mar 2026; they can sell from the next trading day.

What was the Nephrocare Health Services listing gain?

It opened at ₹490.00 against an issue price of ₹460, a gain of 6.52%. It is now up 30.82% from the issue price.